Print…

You Searched For: Clinical+Instruments


8 203  results were found

Refine Results Sort by
SearchResultCount:"8203"

Sort Results

List View Easy View (new)

Rate These Search Results

Image Unavailable-BOSSBS-7974R-A350

Anti-ATXN2 Rabbit Polyclonal Antibody (Alexa Fluor® 350)

Catalog Number: (BOSSBS-7974R-A350)
Supplier: Bioss
Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Image Unavailable-BOSSBS-7974R-A647

Anti-ATXN2 Rabbit Polyclonal Antibody (Alexa Fluor® 647)

Catalog Number: (BOSSBS-7974R-A647)
Supplier: Bioss
Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Image Unavailable-BOSSBS-7974R-FITC

Anti-ATXN2 Rabbit Polyclonal Antibody (FITC (Fluorescein Isothiocyanate))

Catalog Number: (BOSSBS-7974R-FITC)
Supplier: Bioss
Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Image Unavailable-BOSSBS-7974R-HRP

Anti-ATXN2 Rabbit Polyclonal Antibody (HRP (Horseradish Peroxidase))

Catalog Number: (BOSSBS-7974R-HRP)
Supplier: Bioss
Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Image Unavailable-BOSSBS-7974R-A680

Anti-ATX2 Rabbit Polyclonal Antibody (Alexa Fluor® 680)

Catalog Number: (BOSSBS-7974R-A680)
Supplier: Bioss
Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterised by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterised by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Product Image-GOJO9661-24EEU00

PURELL® Advanced Hygienic Hand Rub Bottles

Supplier: GOJO Industries - Europe Ltd
Description: A no-rinse hygienic hand rub that feels great to use and is clinically proven to maintain skin health.

Product Image-113-8322

VWR®, Isolation Gowns

Supplier: VWR Collection
Description: These disposable gowns, with back fastening, are made of non woven, breathable SMS fabric. Ideal for use in healthcare environments and hospitals.

Product Image-113-9408

VWR®, Cleanroom Socks, Non ESD, Disposable

Supplier: VWR Collection
Description: These disposable socks are made of polyester filament yarn.

Certificates Environmentally Preferable

Image Unavailable-BNUB0844-100

Anti-KRT10 Mouse Monoclonal Antibody (Purified) [clone: KRT10/844]

Supplier: Biotium
Description: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNCB0674-100

Anti-KRT10 Mouse Monoclonal Antibody (Biotin) [clone: LH2]

Supplier: Biotium
Description: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNC470674-100

Anti-KRT10 Mouse Monoclonal Antibody (CF647) [clone: LH2]

Supplier: Biotium
Description: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNC880844-100

Anti-KRT10 Mouse Monoclonal Antibody (CF488A) [clone: KRT10/844]

Supplier: Biotium
Description: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNC400844-100

Anti-KRT10 Mouse Monoclonal Antibody (CF640R) [clone: KRT10/844]

Supplier: Biotium
Description: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-MODU397413

VITREX® Ultrasafe Safety Lancet

Catalog Number: (MODU397413)
Supplier: Vitrex Medical A/S
Description: Vitrex Ultrasafe lancet is intended for blood glucose and other in vitro diagnostic tests.
UOM: 1 * 100 items
Product Image-GILI2614010

ASPEC® 274 system

Catalog Number: (GILI2614010)
Supplier: GILSON LCMS
Description: This ASPEC® system for positive pressure solid phase extraction (SPE) automation maximises throughput by processing up to four samples in parallel. With its small footprint and multiple probes, it is the ideal choice for reproducible and efficient sample cleanup for clinical, forensic, doping, food, and environmental testing labs.
UOM: 1 * 1 items
Product Image-630-3467

Upright microscopes, Leica DM4 B and DM6 B

Supplier: LEICA MICROSYSTEMS
Description: Increase your work efficiency with the Leica DM4 B or Leica DM6 B upright digital research microscopes. Both are ideally suited to making your work life easier in biomedical research and clinical labs alike.

Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at +43 1 97002 - 0.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at +43 1 97002 - 0.
Dual use goods can only be delivered within the European Union.
Dual use goods can only be delivered within the European Union.
This product has been blocked by your organization. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
This product is no longer available. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service at +43 1 97002 - 0.
81 - 96 of 8 203
no targeter for Bottom